BMLPAP0110

 

Features

Test data can be obtained within only 40 seconds.

Only 5 uL of finger prick blood is needed.

​

Ministry of Health Medical Device Manufacturing No. 009554

​

Introduction

Lipoprotein(a) is increasingly recognized as a significant, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD). Despite its clinical importance, Lp(a) screening remains underutilized, presenting a substantial opportunity for growth in the diagnostic testing market.​

 

Approximately one in five people worldwide has elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.